响应可溶性MICA的人工嵌合受体修饰NK92细胞的抗肿瘤活性研究.pdf

响应可溶性MICA的人工嵌合受体修饰NK92细胞的抗肿瘤活性研究.pdf

  1. 1、本文档共68页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
目 录 摘要·····························································································1 Abstract·························································································3 前言·····························································································6 材料与方法····················································································9 结果 ··························································································21 讨论 ··························································································31 结论···························································································34 附图···························································································35 参考文献·····················································································37 综述:NKG2D/NKG2DLs在NK 细胞肿瘤免疫治疗中的研究··················42 参考文献·····················································································54 附录···························································································63 攻读学位期间发表文章情况·····························································64 致谢···························································································65 个人简历·····················································································66 新乡医学院硕士学位论文 响应可溶性MICA 的人工嵌合受体修饰NK92细胞的抗肿瘤活 性研究 摘 要 背景 免疫逃逸是癌症难以治愈最重要的特征之一。如何采取有效手段重启被肿瘤免 疫逃逸所阻断的免疫反应,调动免疫细胞对肿瘤细胞的主动杀伤,成为根治肿瘤的 关键问题。基于该理念,以嵌合抗原受体改造T/NK 细胞 (CAR-T/NK)为代表的肿 瘤免疫疗法已取得了肿瘤治疗的新突破。然而,近期发现经CAR-T 治疗的患者出现 较多预后复发案例,这与肿瘤细胞表面抗原丢失造成的免疫逃逸有关。因此,如何 应对肿瘤表面抗原丢失所产生的免疫逃逸成为肿瘤免疫疗法尤其是新一代CAR设计 亟待解决的问题。 目的 分析NKG2D 与配体复合物的蛋白质结构,设计并构建出兼具膜结合型MICA 和可溶性MICA(sMICA)靶向识别与响应能力的嵌合抗原受体,探讨该受体对sMICA 的响应能力,为增强NK92 细胞的抗肿瘤活性研究提供理论依据。 方法 以NK 细胞主要活化受体NKG2D 为CAR 的构

文档评论(0)

136****6583 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:7043055023000005

1亿VIP精品文档

相关文档